Ainos Inc (AIMD)

Over the past six months, Ainos, Inc.'s stock has experienced significant volatility and a notable decline. Key events impacting the stock price include Q3 2025 earnings, which showed AI Nose scale-up and lower expenses, and full year 2025 financial results, which reported revenue growth but also operating losses and reliance on external financing. AI Nose deployments and partnerships were also significant, with announcements of distribution partnerships, live deployments, and industrial-scale deployment roadmaps.

Based on historical data, Ainos, Inc. stock has shown some seasonal tendencies. July has been the strongest month, while November tends to be the weakest month. Overall, the stock has an average annual return of 7.27% with a monthly win rate of 38.3%, and its seasonal pattern has a consistency score of 66.3.

Ainos, Inc. is a dual-platform AI and biotechnology company operating in the healthcare and technology sectors. It focuses on "smelltech" and immune therapeutics. Its major platforms include the AI Nose, which digitizes scent into machine-readable data, and VELDONA, which involves low-dose oral interferon therapeutics. The company was founded in 1984 and has pivoted to its current dual-platform strategy.

Ainos, Inc. is headquartered in San Diego, California, with plans to relocate to Houston, Texas, in early 2026. The company also has a presence in Taiwan (R.O.C.). Its strategy involves outsourced manufacturing and partnerships in Taiwan, and industrial pilots for its AI Nose platform are taking place in semiconductor environments.

Ainos, Inc.'s brand reputation has been influenced by its strategic pivot and technological advancements, alongside financial challenges. The company has gained positive attention for its pioneering work in "Smell AI". However, the company's financial performance, including declining revenue and ongoing operating losses, could negatively impact its reputation among investors.

Ainos, Inc. has 21 institutional owners and shareholders holding a total of 248,546 shares. Major institutional owners include Renaissance Technologies Llc, DRW Securities, LLC, Two Sigma Investments, Lp, Vanguard Group Inc, Mariner, LLC, Citadel Advisors Llc, BlackRock, Inc., Tower Research Capital LLC (TRC), Seneschal Advisors, LLC, and Steward Partners Investment Advisory, Llc. Other significant shareholders include ASE Technology Holding Co., Ltd. and Inabata & Co., Ltd.. The ownership breakdown is approximately 4.3% institutional, 22.7% individual, 38.5% other, and 34.4% unknown.